Regulatory: Regulatory Activity on the Rise Under the Obama Administration
During its first year, the administration effected many changes.
May 11, 2010 at 08:00 PM
6 minute read
The original version of this story was published on Law.com
With its political appointees finally in place, the Obama Administration is implementing an unprecedented flurry of regulatory activity. In addition to its efforts to obtain passage of laws regulating the health care and financial services industries, the Administration will heighten enforcement in the labor, environmental, and food and drug safety areas. Corporations should be prepared for a sharp uptick in the enforcement of existing laws, issuance of new regulations and passage of additional laws that will result in hundreds of new rulemakings over the next few years.
During its first year in office, the Administration secured major increases in the enforcement budgets of the major regulatory agencies to permit more aggressive policing of compliance with existing laws. The Securities and Exchange Commission's fraud action against Goldman Sachs and the Federal Trade Commission's lawsuit against Intel are the hallmarks of this initiative.
A substantial wave of new rulemakings is now following the expanded enforcement effort. The recently passed health care reform legislation and the forthcoming financial regulatory reform bill will be major drivers of this regulatory surge, which will have substantial implications for virtually all companies, whether large or small. For example, by September the Department of Health and Human Services (HHS) must issue several major rules that will affect the costs of every company that offers health insurance to its employees. These rules will require that children under age 26 may be covered under their parents' policies; that children may not be denied coverage due to pre-existing conditions; that insurers may not limit an individual's lifetime benefits; and that insurers may not require individuals to pay for designated preventive services. In January, HHS must issue a rule that requires health plans to spend more than 80 percent of their premiums on health services and make rebates to customers if administrative costs exceed the applicable cap.
On the environmental front, the Environmental Protection Agency (EPA) has proposed a series of very expensive rules that will affect the energy costs and air pollution control obligations of all parts of the manufacturing sector. EPA hopes to persuade Congress to adopt climate change legislation by keeping pressure on industry to develop sector-specific solutions for their carbon dioxide emission, rather than bearing the consequences of the agency's exercise of the inadequate authorities it now possesses.
By this summer, the White House will be swamped by critical HHS and EPA rules that must compete with one another and other regulatory priorities to obtain policy clearance from the President.
John F. Cooney is a partner in the Washington, D.C., office of Venable.
Read John Cooney's next column.
With its political appointees finally in place, the Obama Administration is implementing an unprecedented flurry of regulatory activity. In addition to its efforts to obtain passage of laws regulating the health care and financial services industries, the Administration will heighten enforcement in the labor, environmental, and food and drug safety areas. Corporations should be prepared for a sharp uptick in the enforcement of existing laws, issuance of new regulations and passage of additional laws that will result in hundreds of new rulemakings over the next few years.
During its first year in office, the Administration secured major increases in the enforcement budgets of the major regulatory agencies to permit more aggressive policing of compliance with existing laws. The Securities and Exchange Commission's fraud action against
A substantial wave of new rulemakings is now following the expanded enforcement effort. The recently passed health care reform legislation and the forthcoming financial regulatory reform bill will be major drivers of this regulatory surge, which will have substantial implications for virtually all companies, whether large or small. For example, by September the Department of Health and Human Services (HHS) must issue several major rules that will affect the costs of every company that offers health insurance to its employees. These rules will require that children under age 26 may be covered under their parents' policies; that children may not be denied coverage due to pre-existing conditions; that insurers may not limit an individual's lifetime benefits; and that insurers may not require individuals to pay for designated preventive services. In January, HHS must issue a rule that requires health plans to spend more than 80 percent of their premiums on health services and make rebates to customers if administrative costs exceed the applicable cap.
On the environmental front, the Environmental Protection Agency (EPA) has proposed a series of very expensive rules that will affect the energy costs and air pollution control obligations of all parts of the manufacturing sector. EPA hopes to persuade Congress to adopt climate change legislation by keeping pressure on industry to develop sector-specific solutions for their carbon dioxide emission, rather than bearing the consequences of the agency's exercise of the inadequate authorities it now possesses.
By this summer, the White House will be swamped by critical HHS and EPA rules that must compete with one another and other regulatory priorities to obtain policy clearance from the President.
John F. Cooney is a partner in the Washington, D.C., office of
Read John Cooney's next column.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllWhy Seemingly Simple Off-Channel Communication Rules Still Vex Finance Industry
5 minute readSEC Enforcement Chief Grewal—Whose Hard Line on Crypto Tormented the Industry—Stepping Down
4 minute readTrending Stories
Who Got The Work
Dechert partners Andrew J. Levander, Angela M. Liu and Neil A. Steiner have stepped in to defend Arbor Realty Trust and certain executives in a pending securities class action. The complaint, filed July 31 in New York Eastern District Court by Levi & Korsinsky, contends that the defendants concealed a 'toxic' mobile home portfolio, vastly overstated collateral in regards to the company's loans and failed to disclose an investigation of the company by the FBI. The case, assigned to U.S. District Judge Pamela K. Chen, is 1:24-cv-05347, Martin v. Arbor Realty Trust, Inc. et al.
Who Got The Work
Arthur G. Jakoby, Ryan Feeney and Maxim M.L. Nowak from Herrick Feinstein have stepped in to defend Charles Dilluvio and Seacor Capital in a pending securities lawsuit. The complaint, filed Sept. 30 in New York Southern District Court by the Securities and Exchange Commission, accuses the defendants of using consulting agreements, attorney opinion letters and other mechanisms to skirt regulations limiting stock sales by affiliate companies and allowing the defendants to unlawfully profit from sales of Enzolytics stock. The case, assigned to U.S. District Judge Andrew L. Carter Jr., is 1:24-cv-07362, Securities and Exchange Commission v. Zhabilov et al.
Who Got The Work
Clark Hill members Vincent Roskovensky and Kevin B. Watson have entered appearances for Architectural Steel and Associated Products in a pending environmental lawsuit. The complaint, filed Aug. 27 in Pennsylvania Eastern District Court by Brodsky & Smith on behalf of Hung Trinh, accuses the defendant of discharging polluted stormwater from its steel facility without a permit in violation of the Clean Water Act. The case, assigned to U.S. District Judge Gerald J. Pappert, is 2:24-cv-04490, Trinh v. Architectural Steel And Associated Products, Inc.
Who Got The Work
Michael R. Yellin of Cole Schotz has entered an appearance for S2 d/b/a the Shoe Surgeon, Dominic Chambrone a/k/a Dominic Ciambrone and other defendants in a pending trademark infringement lawsuit. The case, filed July 15 in New York Southern District Court by DLA Piper on behalf of Nike, seeks to enjoin Ciambrone and the other defendants in their attempts to build an 'entire multifaceted' retail empire through their unauthorized use of Nike’s trademark rights. The case, assigned to U.S. District Judge Naomi Reice Buchwald, is 1:24-cv-05307, Nike Inc. v. S2, Inc. et al.
Who Got The Work
Sullivan & Cromwell partner Adam S. Paris has entered an appearance for Orthofix Medical in a pending securities class action arising from a proposed acquisition of SeaSpine by Orthofix. The suit, filed Sept. 6 in California Southern District Court, by Girard Sharp and the Hall Firm, contends that the offering materials and related oral communications contained untrue statements of material fact. According to the complaint, the defendants made a series of misrepresentations about Orthofix’s disclosure controls and internal controls over financial reporting and ethical compliance. The case, assigned to U.S. District Judge Linda Lopez, is 3:24-cv-01593, O'Hara v. Orthofix Medical Inc. et al.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250